Published in Tumori on May 04, 2010
Management of radiation oncology patients with a pacemaker or ICD: a new comprehensive practical guideline in The Netherlands. Dutch Society of Radiotherapy and Oncology (NVRO). Radiat Oncol (2012) 1.09
[Radiation therapy in patients with cardiac pacemakers or implantable cardioverter defibrillators. Interdisciplinary safety recommendations]. Strahlenther Onkol (2012) 0.78
A case of radiotherapy for an advanced bronchial carcinoma patient with implanted cardiac rhythm machines as well as heart assist device. Radiat Oncol (2015) 0.75
Does tumor growth follow a "universal law"? J Theor Biol (2003) 2.47
Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer. J Natl Cancer Inst (2011) 2.47
Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys (2010) 1.77
Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival. Ann Surg Oncol (2006) 1.45
Predictors for rectal and intestinal acute toxicities during prostate cancer high-dose 3D-CRT: results of a prospective multicenter study. Int J Radiat Oncol Biol Phys (2007) 1.23
Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging. Eur Radiol (2008) 1.20
Intensity-modulated radiation therapy in oropharyngeal carcinoma: effect of tumor volume on clinical outcomes. Int J Radiat Oncol Biol Phys (2011) 1.17
Emptying the rectum before treatment delivery limits the variations of rectal dose - volume parameters during 3DCRT of prostate cancer. Radiother Oncol (2006) 1.08
Quality indicators in radiotherapy. Radiother Oncol (2007) 1.08
Development of a set of nomograms to predict acute lower gastrointestinal toxicity for prostate cancer 3D-CRT. Int J Radiat Oncol Biol Phys (2008) 1.07
Clinical and dosimetric predictors of late rectal toxicity after conformal radiation for localized prostate cancer: results of a large multicenter observational study. Radiother Oncol (2009) 1.06
Accelerated versus conventional fractionated postoperative radiotherapy for advanced head and neck cancer: results of a multicenter Phase III study. Int J Radiat Oncol Biol Phys (2005) 0.98
Clinical validation of atlas-based auto-segmentation of pelvic volumes and normal tissue in rectal tumors using auto-segmentation computed system. Acta Oncol (2013) 0.97
Hyperthermia inhibits angiogenesis by a plasminogen activator inhibitor 1-dependent mechanism. Cancer Res (2003) 0.96
A prospective observational trial on emesis in radiotherapy: analysis of 1020 patients recruited in 45 Italian radiation oncology centres. Radiother Oncol (2009) 0.95
Target volume delineation in oropharyngeal cancer: impact of PET, MRI, and physical examination. Int J Radiat Oncol Biol Phys (2011) 0.93
Accessibility as a major determinant of radiotherapy underutilization: a population based study. Health Policy (2006) 0.90
Induction chemotherapy with carboplatin and taxol followed by radiotherapy and concurrent weekly carboplatin + taxol in locally advanced nasopharyngeal carcinoma. Cancer Chemother Pharmacol (2010) 0.90
Definitive treatment of metastatic nasopharyngeal carcinoma: Report of 5 cases with review of literature. Head Neck (2010) 0.89
Surgery and radiotherapy in the treatment of malignant parotid tumors: a retrospective multicenter study. Tumori (2009) 0.88
Docetaxel and vinorelbine: an effective regimen in recurrent squamous cell esophageal carcinoma. Med Oncol (2003) 0.88
Is it time to tailor the prediction of radio-induced toxicity in prostate cancer patients? Building the first set of nomograms for late rectal syndrome. Int J Radiat Oncol Biol Phys (2011) 0.87
Laparotomy wound recurrence of endometrial carcinoma. Gynecol Oncol (2003) 0.87
Clinical and biological prognostic factors in 179 cases with sinonasal carcinoma treated in the Italian Piedmont region. Oncology (2009) 0.85
Chondrosarcoma of the nasal septum. Eur Arch Otorhinolaryngol (2014) 0.84
External beam radiotherapy plus high-dose-rate brachytherapy for treatment of locally advanced prostate cancer: the initial experience of the Catalan Institute of Oncology. Brachytherapy (2009) 0.83
Increasing the risk of late rectal bleeding after high-dose radiotherapy for prostate cancer: the case of previous abdominal surgery. Results from a prospective trial. Radiother Oncol (2012) 0.83
Impact of the radiotherapy technique on the correlation between dose-volume histograms of the bladder wall defined on MRI imaging and dose-volume/surface histograms in prostate cancer patients. Phys Med Biol (2013) 0.82
Clinical and technical feasibility of ultra-boost irradiation in Dominant Intraprostatic Lesion by Tomotherapy: preliminary experience and revision of literature. Panminerva Med (2015) 0.81
Prospective phase II trial of neoadjuvant chemo-radiotherapy with Oxaliplatin and Capecitabine in locally advanced rectal cancer (XELOXART). Med Oncol (2013) 0.81
Quality assurance of a record-and-verify system. Tumori (2009) 0.80
Tomotherapy treatment plan quality assurance: the impact of applied criteria on passing rate in gamma index method. Med Phys (2013) 0.79
Prostate image-guided radiotherapy by megavolt cone-beam CT. Strahlenther Onkol (2011) 0.78
Paclitaxel and carboplatin in neo-adjuvant and concomitant chemoradiotherapy in locally advanced head and neck squamous cell carcinoma. Tumori (2003) 0.78
Impact of age at diagnosis on overall and disease-free survival in men with prostate cancer following conformal 3D radiation therapy. Tumori (2012) 0.78
Feasibility of intensity-modulated radiation therapy in the treatment of advanced cervical chordoma. Tumori (2003) 0.78
Carboplatin plus taxol is an effective third-line regimen in recurrent undifferentiated nasopharyngeal carcinoma. Tumori (2002) 0.78
Dose to organs at risk in the upper abdomen in patients treated with extended fields by helical tomotherapy: a dosimetric and clinical preliminary study. Radiat Oncol (2013) 0.77
Quality assurance of 3D-CRT: indications and difficulties in their applications. Crit Rev Oncol Hematol (2008) 0.77
Are quality indicators for radiotherapy useful in the evaluation of service efficacy in a new based radiotherapy institution? Tumori (2007) 0.77
Radiotherapy after partial laryngectomy: an analysis of 36 cases and a proposal to optimize radiotherapy. Tumori (2009) 0.77
Clinical application and dosimetric calibration procedure of the superficial and orthovoltage therapy unit Therapax DXT300. Tumori (2002) 0.77
Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society. Tumori (2014) 0.77
Salvage external beam radiotherapy for recurrent prostate adenocarcinoma after high-intensity focused ultrasound as primary treatment. Urol Int (2013) 0.77
Comparison of endorectal magnetic resonance imaging, clinical prognostic factors and nomograms in the local staging of prostate cancer patients treated with radiotherapy. Tumori (2008) 0.76
Gemcitabine and vinorelbine in recurrent head and neck cancer: pharmacokinetic and clinical results. Anticancer Res (2003) 0.76
Dosimetric evaluation of two radiotherapy treatment planning systems using report 55 by the AAPM task group 23. Tumori (2002) 0.75
Absence of left atrial stunning after cardioversion of recent-onset atrial fibrillation in patients at low-stroke risk. Eur J Emerg Med (2017) 0.75
Is one Gy always one Gy? The integration between conventional radiotherapy and special techniques. Rays (2004) 0.75
Technical and clinical description of a case of extensive anogenital Paget's disease associated with anal cancer treated by tomotherapy. Tumori (2014) 0.75
Internal radiation by 131-iodine lipiodol in unresectable hepatocellular carcinoma. Dig Liver Dis (2013) 0.75
External beam radiotherapy with dose escalation in 1080 prostate cancer patients: definitive outcome and dose impact. Panminerva Med (2016) 0.75
Hereditary paraganglioma syndrome associated with SDHD gene mutations: a patient with multicentric presentation treated with radiotherapy. Case report. Tumori (2011) 0.75
Diarrhoea in irradiated patients: a prospective multicentre observational study. Dig Liver Dis (2013) 0.75
Percentage of positive prostate biopsies independently predicts biochemical outcome following radiation therapy for prostate cancer. Panminerva Med (2015) 0.75
A simple and accurate dosimetry protocol to estimate activity for hyperthyroidism treatment. Nucl Med Rev Cent East Eur (2015) 0.75
Italian survey in postoperative radiation therapy for prostate carcinoma by the AIRO National Working Group on Prostate Radiotherapy: definitive results. Tumori (2005) 0.75
A fully automatic method to register the prostate gland on T2-weighted and EPI-DWI images. Conf Proc IEEE Eng Med Biol Soc (2011) 0.75
Scleromyxedema: treatment of widespread cutaneous involvement by total skin electron-beam therapy. Int J Dermatol (2007) 0.75